GammaOmics

GammaOmics focuses on cutting-edge single-cell technologies, offering unparalleled insights into complex immuno-metabolic profiles. Our SCENITH™ technology provides single-cell resolution, allowing researchers to study rare cells and compare metabolic profiles with ease. Benefits and importance of single cell analysis. GammaOmics is a biotechnology company specializing in functional metabolic profiling, with a strong focus on human immunometabolism. We hold exclusive global rights to offer SCENITH™ products and services—an advanced technology enabling single-cell metabolic profiling ex vivo. Our mission is to democratize access to functional immunometabolism studies, driving the development of personalized medicine solutions to improve next-generation therapies, including cell-based therapies (quality control and patient monitoring), antibody treatments, and targeted therapies. We are particularly focused on multi-omics and pre-/ clinical sample analysis, clinical trials, and tracking responses to treatment. By integrating artificial intelligence into our analysis pipelines, we provide deep insights into cell type-specific metabolic shifts and their correlation with treatment outcomes, ultimately advancing precision medicine.